Myriad Genetics Long Term Debt 2010-2024 | MYGN

Myriad Genetics long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Myriad Genetics Annual Long Term Debt
(Millions of US $)
2023 $39
2022 $
2021 $
2020 $225
2020 $224
2019 $234
2018 $9
2017 $99
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
Myriad Genetics Quarterly Long Term Debt
(Millions of US $)
2024-03-31 $39
2023-12-31 $39
2023-09-30 $39
2023-06-30 $38
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31 $154
2020-12-31 $225
2020-09-30 $225
2020-06-30 $224
2020-03-31 $225
2019-12-31 $225
2019-09-30 $225
2019-06-30 $234
2019-03-31 $263
2018-12-31 $273
2018-09-30 $258
2018-06-30 $9
2018-03-31 $69
2017-12-31 $43
2017-09-30 $74
2017-06-30 $99
2017-03-31 $167
2016-12-31 $204
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.163B $0.753B
Myriad Genetics employs a number of proprietary technologies to target the genetic basis of human diseases and the role these genes might play in the onset, progression and treatment of the respective diseases. The company has more than 10 proprietary molecular diagnostic products in market. It has made significant progress in transition & expand the hereditary cancer market, diversify revenues by commercializing its new products, increase the company's international contribution by investing in large countries, gaining reimbursement for new products, increasing international RNA kit revenue and enhancing profitability. Its flagship product BRACAnalysis offers a comprehensive analysis of BRCA1 and BRCA2 genes to assess a woman's risk of hereditary breast and ovarian cancers. Its major products are myRisk Hereditary Cancer, myPlan Lung Cancer and molecular diagnostic test myPath Melanoma. It acquired Counsyl, Inc. The company has 2 operating units: Molecular diagnostic & Pharmaceutical and clinical services.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $164.144B 16.42
Vertex Pharmaceuticals (VRTX) United States $120.583B 31.03
Regeneron Pharmaceuticals (REGN) United States $114.495B 28.00
CSL (CSLLY) Australia $94.263B 0.00
GSK (GSK) United Kingdom $84.866B 10.14
Bristol Myers Squibb (BMY) United States $82.726B 38.87
Gilead Sciences (GILD) United States $78.676B 15.67
Moderna (MRNA) United States $51.074B 0.00
Biogen (BIIB) United States $32.563B 14.91
Argenex SE (ARGX) Netherlands $22.463B 0.00
BioNTech SE (BNTX) Germany $20.509B 172.54
Alnylam Pharmaceuticals (ALNY) United States $19.462B 0.00
Illumina (ILMN) United States $17.220B 122.84
Genmab (GMAB) Denmark $17.062B 20.00
BioMarin Pharmaceutical (BMRN) United States $15.978B 62.33
BeiGene (BGNE) Cayman Islands $14.823B 0.00
Incyte (INCY) United States $13.796B 21.33
Bio-Techne Corp (TECH) United States $11.746B 44.37
Sarepta Therapeutics (SRPT) United States $11.108B 979.33
QIAGEN (QGEN) Netherlands $9.984B 21.33
Insmed (INSM) United States $9.745B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.085B 26.44
Roivant Sciences (ROIV) United Kingdom $8.008B 0.00
Intra-Cellular Therapies (ITCI) United States $7.969B 0.00
Vaxcyte (PCVX) United States $7.860B 0.00
Exact Sciences (EXAS) United States $7.735B 0.00
Legend Biotech (LEGN) United States $7.379B 0.00
Ascendis Pharma (ASND) Denmark $7.173B 0.00
Repligen (RGEN) United States $6.873B 89.78
Blueprint Medicines (BPMC) United States $6.682B 0.00
Exelixis (EXEL) United States $6.537B 33.69
Halozyme Therapeutics (HALO) United States $6.398B 17.76
Viking Therapeutics (VKTX) United States $5.584B 0.00
Cytokinetics (CYTK) United States $5.446B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.143B 0.00
Nuvalent (NUVL) United States $5.042B 0.00
Krystal Biotech (KRYS) United States $4.941B 0.00
Apellis Pharmaceuticals (APLS) United States $4.863B 0.00
Zealand Pharma (ZLDPF) Denmark $4.677B 0.00
ImmunityBio (IBRX) United States $4.308B 0.00
Alkermes (ALKS) Ireland $4.132B 16.17
Immunovant (IMVT) United States $3.825B 0.00
Avidity Biosciences (RNA) United States $3.666B 0.00
Guardant Health (GH) United States $3.664B 0.00
Axsome Therapeutics (AXSM) United States $3.611B 0.00
Merus (MRUS) Netherlands $3.183B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.111B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.103B 0.00
Twist Bioscience (TWST) United States $2.944B 0.00
Denali Therapeutics (DNLI) United States $2.941B 0.00
Amicus Therapeutics (FOLD) United States $2.894B 0.00
Biohaven (BHVN) United States $2.893B 0.00
Arcellx (ACLX) United States $2.879B 0.00
IDEAYA Biosciences (IDYA) United States $2.821B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.736B 0.00
MorphoSys AG (MOR) Germany $2.729B 0.00
SpringWorks Therapeutics (SWTX) United States $2.683B 0.00
Geron (GERN) United States $2.663B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.524B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.523B 0.00
ADMA Biologics Inc (ADMA) United States $2.462B 96.54
ACADIA Pharmaceuticals (ACAD) United States $2.457B 0.00
Intellia Therapeutics (NTLA) United States $2.393B 0.00
Celldex Therapeutics (CLDX) United States $2.284B 0.00
CG Oncology (CGON) United States $2.258B 0.00
Iovance Biotherapeutics (IOVA) United States $2.239B 0.00
Structure Therapeutics (GPCR) United States $2.215B 0.00
Certara (CERT) United States $2.150B 49.52
Apogee Therapeutics (APGE) United States $2.126B 0.00
Vericel (VCEL) United States $2.108B 0.00
Janux Therapeutics (JANX) United States $2.095B 0.00
Fortrea Holdings (FTRE) United States $2.087B 25.65
Vera Therapeutics (VERA) United States $1.944B 0.00
Novavax (NVAX) United States $1.935B 0.00
Kymera Therapeutics (KYMR) United States $1.914B 0.00
Protagonist Therapeutics (PTGX) United States $1.911B 13.36
Beam Therapeutics (BEAM) United States $1.907B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.877B 0.00
Zai Lab (ZLAB) China $1.867B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.797B 0.00
Bavarian Nordic (BVNRY) Denmark $1.774B 7.72
Galapagos (GLPG) Belgium $1.703B 0.00
Arvinas (ARVN) United States $1.698B 0.00
NeoGenomics (NEO) United States $1.662B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.641B 12.51
Syndax Pharmaceuticals (SNDX) United States $1.620B 0.00
Keros Therapeutics (KROS) United States $1.611B 0.00
Akero Therapeutics (AKRO) United States $1.532B 0.00
Edgewise Therapeutics (EWTX) United States $1.511B 0.00
Kura Oncology (KURA) United States $1.506B 0.00
Belite Bio (BLTE) United States $1.479B 0.00
Dynavax Technologies (DVAX) United States $1.476B 188.00
Neumora Therapeutics (NMRA) United States $1.460B 0.00
Arcus Biosciences (RCUS) United States $1.454B 0.00
Ligand Pharmaceuticals (LGND) United States $1.450B 23.69
Mirum Pharmaceuticals (MIRM) United States $1.379B 0.00
Morphic Holding (MORF) United States $1.310B 0.00
MannKind (MNKD) United States $1.302B 159.33
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.291B 0.00
ANI Pharmaceuticals (ANIP) United States $1.274B 15.82
Sana Biotechnology (SANA) United States $1.258B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.253B 0.00
Vir Biotechnology (VIR) United States $1.218B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.170B 0.00
Disc Medicine (IRON) United States $1.076B 0.00
Immatics (IMTX) Germany $1.065B 0.00
Prothena (PRTA) Ireland $1.051B 0.00
Spyre Therapeutics (SYRE) United States $1.039B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.038B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.031B 0.00
MiMedx (MDXG) United States $1.020B 43.19
Tango Therapeutics (TNGX) United States $1.019B 0.00
Cullinan Therapeutics (CGEM) United States $0.969B 0.00
Liquidia Technologies (LQDA) United States $0.956B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.943B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.931B 0.00
Gyre Therapeutics (GYRE) United States $0.924B 0.00
Nurix Therapeutics (NRIX) United States $0.906B 0.00
Tyra Biosciences (TYRA) United States $0.904B 0.00
Rapport Therapeutics (RAPP) $0.894B 0.00
AbCellera Biologics (ABCL) Canada $0.888B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.888B 0.00
Mesoblast (MESO) Australia $0.855B 0.00
Abivax SA (ABVX) France $0.838B 0.00
89BIO (ETNB) United States $0.826B 0.00
Cogent Biosciences (COGT) United States $0.813B 0.00
Immunome (IMNM) United States $0.796B 0.00
Stoke Therapeutics (STOK) United States $0.785B 0.00
Viridian Therapeutics (VRDN) United States $0.777B 0.00
Prime Medicine (PRME) United States $0.754B 0.00
PureTech Health (PRTC) United States $0.749B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.739B 0.00
Cytek Biosciences (CTKB) United States $0.736B 0.00
Dianthus Therapeutics (DNTH) United States $0.730B 0.00
CureVac (CVAC) Germany $0.728B 0.00
Nuvation Bio (NUVB) United States $0.717B 0.00
Humacyte (HUMA) United States $0.707B 0.00
WAVE Life Sciences (WVE) Singapore $0.699B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.699B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.695B 0.00
Scholar Rock Holding (SRRK) United States $0.677B 0.00
Olema Pharmaceuticals (OLMA) United States $0.671B 0.00
Pliant Therapeutics (PLRX) United States $0.646B 0.00
Praxis Precision Medicines (PRAX) United States $0.645B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
HilleVax (HLVX) United States $0.636B 0.00
AnaptysBio (ANAB) United States $0.625B 0.00
GH Research (GHRS) Ireland $0.622B 0.00
Castle Biosciences (CSTL) United States $0.612B 0.00
CARGO Therapeutics (CRGX) United States $0.608B 0.00
Pharming Group (PHGUF) Netherlands $0.606B 0.00
Zymeworks (ZYME) United States $0.602B 0.00
REGENXBIO (RGNX) United States $0.601B 0.00
ArriVent BioPharma (AVBP) United States $0.586B 0.00
Mineralys Therapeutics (MLYS) United States $0.585B 0.00
Northwest Biotherapeutics (NWBO) United States $0.576B 0.00
Pharming Group (PHAR) Netherlands $0.576B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.571B 0.00
Arbutus Biopharma (ABUS) United States $0.568B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.558B 0.00
Travere Therapeutics (TVTX) United States $0.541B 0.00
ITeos Therapeutics (ITOS) United States $0.540B 0.00
PepGen (PEPG) United States $0.530B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.523B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.514B 0.00
Applied Therapeutics (APLT) United States $0.514B 0.00
Third Harmonic Bio (THRD) United States $0.505B 0.00
Entrada Therapeutics (TRDA) United States $0.499B 23.48
Astria Therapeutics (ATXS) United States $0.494B 0.00
Contineum Therapeutics (CTNM) United States $0.490B 0.00
Oric Pharmaceuticals (ORIC) United States $0.484B 0.00
Terns Pharmaceuticals (TERN) United States $0.477B 0.00
Oculis Holding AG (OCS) Switzerland $0.476B 0.00
Avid Bioservices (CDMO) United States $0.472B 0.00
Replimune (REPL) United States $0.469B 0.00
Annexon (ANNX) United States $0.469B 0.00
Allogene Therapeutics (ALLO) United States $0.466B 0.00
Celcuity (CELC) United States $0.465B 0.00
MaxCyte (MXCT) United States $0.460B 0.00
Adaptive Biotechnologies (ADPT) United States $0.454B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.453B 0.00
Voyager Therapeutics (VYGR) United States $0.444B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.431B 0.00
IGM Biosciences (IGMS) United States $0.427B 0.00
ACELYRIN, INC (SLRN) United States $0.416B 0.00
Editas Medicine (EDIT) United States $0.414B 0.00
Alector (ALEC) United States $0.411B 0.00
Fulcrum Therapeutics (FULC) United States $0.403B 0.00
Cabaletta Bio (CABA) United States $0.403B 0.00
AC Immune (ACIU) Switzerland $0.403B 0.00
Precigen (PGEN) United States $0.396B 0.00
Urogen Pharma (URGN) United States $0.396B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.395B 0.00
Neurogene (NGNE) United States $0.394B 0.00
Absci (ABSI) United States $0.394B 0.00
Fate Therapeutics (FATE) United States $0.388B 0.00
Cartesian Therapeutics (RNAC) United States $0.387B 0.00
Anika Therapeutics (ANIK) United States $0.378B 324.12
Vanda Pharmaceuticals (VNDA) United States $0.369B 0.00
TScan Therapeutics (TCRX) United States $0.367B 0.00
EnGene Holdings (ENGN) United States $0.364B 0.00
ALX Oncology Holdings (ALXO) United States $0.361B 0.00
Ocugen (OCGN) United States $0.355B 0.00
Erasca (ERAS) United States $0.354B 0.00
Jasper Therapeutics (JSPR) United States $0.349B 0.00
Aura Biosciences (AURA) United States $0.349B 0.00
Scilex Holding (SCLX) United States $0.332B 0.00
Anavex Life Sciences (AVXL) United States $0.328B 0.00
Kyverna Therapeutics (KYTX) United States $0.321B 0.00
Emergent Biosolutions (EBS) United States $0.318B 0.00
Nautilus Biotechnology (NAUT) United States $0.302B 0.00
Amarin (AMRN) Ireland $0.300B 0.00
Alto Neuroscience (ANRO) United States $0.300B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.294B 0.00
Atea Pharmaceuticals (AVIR) United States $0.294B 0.00
Revance Therapeutics (RVNC) United States $0.292B 0.00
Molecular Partners AG (MOLN) Switzerland $0.292B 0.00
Kamada (KMDA) Israel $0.291B 22.00
C4 Therapeutics (CCCC) United States $0.281B 0.00
MeiraGTx Holdings (MGTX) United States $0.275B 0.00
Agenus (AGEN) United States $0.273B 0.00
Inozyme Pharma (INZY) United States $0.272B 0.00
Skye Bioscience (SKYE) United States $0.267B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.266B 0.00
Solid Biosciences (SLDB) United States $0.261B 0.00
Nkarta (NKTX) United States $0.260B 0.00
XOMA (XOMA) United States $0.260B 0.00
Poseida Therapeutics (PSTX) United States $0.256B 0.00
Mersana Therapeutics (MRSN) United States $0.250B 0.00
Sutro Biopharma (STRO) United States $0.249B 0.00
Tenaya Therapeutics (TNYA) United States $0.248B 0.00
CorMedix Inc (CRMD) United States $0.238B 0.00
Prima BioMed (IMMP) Australia $0.226B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.225B 0.00
UniQure (QURE) Netherlands $0.222B 0.00
Inovio Pharmaceuticals (INO) United States $0.222B 0.00
Shattuck Labs (STTK) United States $0.218B 0.00
Q32 Bio (QTTB) United States $0.217B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.217B 0.00
Renovaro (RENB) United States $0.214B 0.00
Inhibrx Biosciences (INBX) $0.211B 0.00
ChromaDex (CDXC) United States $0.208B 0.00
GENFIT S.A (GNFT) France $0.207B 0.00
Greenwich LifeSciences (GLSI) United States $0.206B 0.00
FibroBiologics (FBLG) United States $0.203B 0.00
23andMe Holding (ME) United States $0.200B 0.00
Design Therapeutics (DSGN) United States $0.200B 0.00
2seventy Bio (TSVT) United States $0.200B 0.00
Candel Therapeutics (CADL) United States $0.200B 0.00
Rani Therapeutics Holdings (RANI) United States $0.196B 0.00
Ventyx Biosciences (VTYX) United States $0.194B 0.00
Codexis (CDXS) United States $0.193B 0.00
Trevi Therapeutics (TRVI) United States $0.189B 0.00
Abeona Therapeutics (ABEO) United States $0.186B 0.00
Coherus BioSciences (CHRS) United States $0.186B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.179B 0.00
Biomea Fusion (BMEA) United States $0.174B 0.00
Invivyd (IVVD) United States $0.167B 0.00
Oncobiologics (OTLK) United States $0.165B 0.00
Innate Pharma S.A (IPHA) France $0.163B 0.00
X4 Pharmaceuticals (XFOR) United States $0.162B 0.00
Compugen (CGEN) Israel $0.161B 0.00
XBiotech (XBIT) United States $0.160B 0.00
Alimera Sciences (ALIM) United States $0.160B 0.00
Rezolute (RZLT) United States $0.156B 0.00
Compass Therapeutics (CMPX) United States $0.154B 0.00
Repare Therapeutics (RPTX) Canada $0.154B 0.00
INmune Bio (INMB) United States $0.152B 0.00
Elevation Oncology (ELEV) United States $0.151B 0.00
Puma Biotechnology (PBYI) United States $0.149B 9.36
Lifecore Biomedical (LFCR) United States $0.148B 0.00
Caribou Biosciences (CRBU) United States $0.148B 0.00
Zura Bio (ZURA) United States $0.147B 0.00
Vigil Neuroscience (VIGL) United States $0.145B 0.00
ScPharmaceuticals (SCPH) United States $0.144B 0.00
I-Mab (IMAB) China $0.143B 0.00
Syros Pharmaceuticals (SYRS) United States $0.143B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.140B 0.00
Inventiva S.A (IVA) France $0.138B 0.00
Kodiak Sciences (KOD) United States $0.137B 0.00
Adverum Biotechnologies (ADVM) United States $0.137B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.135B 0.00
G1 Therapeutics (GTHX) United States $0.134B 0.00
Boundless Bio (BOLD) United States $0.133B 0.00
Semper Paratus Acquisition (TVGN) United States $0.133B 0.00
Werewolf Therapeutics (HOWL) United States $0.126B 0.00
TELA Bio (TELA) United States $0.125B 0.00
Adlai Nortye (ANL) Cayman Islands $0.124B 0.00
Gossamer Bio (GOSS) United States $0.123B 0.00
Omega Therapeutics (OMGA) United States $0.122B 0.00
Sagimet Biosciences (SGMT) United States $0.120B 0.00
CervoMed (CRVO) United States $0.120B 0.00
Nuvectis Pharma (NVCT) United States $0.118B 0.00
Adagene (ADAG) China $0.117B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.117B 0.00
BioStem Technologies (BSEM) $0.115B 0.00
ATyr Pharma (ATYR) United States $0.114B 0.00
Cellectis S.A (CLLS) France $0.112B 0.00
Cardiff Oncology (CRDF) United States $0.112B 0.00
Rapt Therapeutics (RAPT) United States $0.111B 0.00
BeyondSpring (BYSI) United States $0.111B 0.00
Adicet Bio (ACET) United States $0.110B 0.00
Opthea (OPT) Australia $0.109B 0.00
Seer (SEER) United States $0.108B 0.00
Seres Therapeutics (MCRB) United States $0.108B 0.00
Akoya Biosciences (AKYA) United States $0.106B 0.00
CytomX Therapeutics (CTMX) United States $0.101B 6.45
PDS Biotechnology (PDSB) United States $0.101B 0.00
Athira Pharma (ATHA) United States $0.100B 0.00
Bluebird Bio (BLUE) United States $0.100B 0.00
Allakos (ALLK) United States $0.099B 0.00
BioHarvest Sciences (CNVCD) Canada $0.098B 0.00
Immunic (IMUX) United States $0.097B 0.00
Coya Therapeutics (COYA) United States $0.095B 0.00
DBV Technologies S.A (DBVT) France $0.094B 0.00
Affimed (AFMD) Germany $0.092B 0.00
VistaGen Therapeutics (VTGN) United States $0.089B 0.00
DiaMedica Therapeutics (DMAC) United States $0.088B 0.00
Sangamo Therapeutics (SGMO) United States $0.087B 0.00
InflaRx (IFRX) Germany $0.086B 0.00
Gritstone Bio (GRTS) United States $0.084B 0.00
Eton Pharmaceuticals (ETON) United States $0.084B 81.50
Clearside Biomedical (CLSD) United States $0.084B 0.00
Verastem (VSTM) United States $0.083B 0.00
IO Biotech (IOBT) Denmark $0.082B 0.00
Connect Biopharma Holdings (CNTB) United States $0.082B 0.00
Ikena Oncology (IKNA) United States $0.082B 0.00
Vor Biopharma (VOR) $0.082B 0.00
Genelux (GNLX) United States $0.081B 0.00
Cognition Therapeutics (CGTX) United States $0.081B 0.00
Elutia (ELUT) United States $0.079B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.079B 0.00
Oncolytics Biotech (ONCY) Canada $0.078B 0.00
Earth Science Tech (ETST) United States $0.078B 0.00
BioAtla (BCAB) United States $0.077B 0.00
Entera Bio (ENTX) Israel $0.076B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.074B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.074B 0.00
Elicio Therapeutics (ELTX) United States $0.073B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.072B 0.00
Precision BioSciences (DTIL) United States $0.070B 0.00
HOOKIPA Pharma (HOOK) United States $0.070B 0.00
Checkpoint Therapeutics (CKPT) United States $0.069B 0.00
Spero Therapeutics (SPRO) United States $0.069B 2.49
Benitec Biopharma (BNTC) United States $0.068B 0.00
Aileron Therapeutics (ALRN) United States $0.067B 0.00
Intensity Therapeutics (INTS) United States $0.067B 0.00
LENZ Therapeutics (LENZ) United States $0.067B 0.00
LakeShore Biopharma (LSB) China $0.067B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.066B 0.00
Cue Biopharma (CUE) United States $0.066B 0.00
Alpha Teknova (TKNO) United States $0.065B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.065B 0.00
MediciNova (MNOV) United States $0.064B 0.00
Instil Bio (TIL) United States $0.064B 0.00
AVROBIO (AVRO) United States $0.064B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.063B 0.00
Turnstone Biologics (TSBX) United States $0.063B 0.00
Galena Biopharma (SLS) United States $0.061B 0.00
Kronos Bio (KRON) United States $0.061B 0.00
Theratechnologies (THTX) Canada $0.061B 0.00
AN2 Therapeutics (ANTX) United States $0.060B 0.00
Annovis Bio (ANVS) United States $0.059B 0.00
Passage Bio (PASG) United States $0.059B 0.00
Genenta Science S.p.A (GNTA) Italy $0.059B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.058B 0.00
Rallybio (RLYB) United States $0.058B 0.00
Celularity (CELU) United States $0.058B 0.00
VTv Therapeutics (VTVT) United States $0.057B 0.00
Ovid Therapeutics (OVID) United States $0.056B 0.00
Enzo Biochem (ENZ) United States $0.056B 0.00
Cidara Therapeutics (CDTX) United States $0.055B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.054B 0.00
CalciMedica (CALC) United States $0.054B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.053B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.053B 0.00
Immix Biopharma (IMMX) United States $0.053B 0.00
Bionano Genomics (BNGO) United States $0.052B 0.00
Dyadic (DYAI) United States $0.051B 0.00
Lantern Pharma (LTRN) United States $0.050B 0.00
Ocean Biomedical (OCEA) United States $0.050B 0.00
Leap Therapeutics (LPTX) United States $0.050B 0.00
Clene (CLNN) United States $0.049B 0.00
ARCA Biopharma (ABIO) United States $0.048B 0.00
Kezar Life Sciences (KZR) United States $0.048B 0.00
Atara Biotherapeutics (ATRA) United States $0.048B 0.00
Curis (CRIS) United States $0.046B 0.00
BioXcel Therapeutics (BTAI) United States $0.046B 0.00
Beyond Air (XAIR) United States $0.045B 0.00
IN8bio (INAB) United States $0.044B 0.00
Immuneering (IMRX) United States $0.044B 0.00
Dare Bioscience (DARE) United States $0.043B 0.00
Aerovate Therapeutics (AVTE) United States $0.041B 0.00
Ocuphire Pharma (OCUP) United States $0.040B 0.00
Aadi Bioscience (AADI) United States $0.040B 0.00
HCW Biologics (HCWB) United States $0.039B 0.00
Lexaria Bioscience (LEXX) Canada $0.038B 0.00
NextCure (NXTC) United States $0.037B 0.00
OKYO Pharma (OKYO) $0.037B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.037B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.036B 0.00
Fortress Biotech (FBIO) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Carmell (CTCX) United States $0.035B 0.00
Eyenovia (EYEN) United States $0.034B 0.00
Cyclo Therapeutics (CYTH) United States $0.033B 0.00
Aligos Therapeutics (ALGS) United States $0.033B 0.00
RenovoRx (RNXT) United States $0.033B 0.00
Pluri (PLUR) Israel $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
NKGen Biotech (NKGN) United States $0.030B 0.00
Estrella Immunopharma (ESLA) United States $0.030B 0.00
Quince Therapeutics (QNCX) United States $0.029B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.028B 0.00
Bolt Biotherapeutics (BOLT) United States $0.028B 0.00
Lisata Therapeutics (LSTA) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Spruce Biosciences (SPRB) United States $0.026B 0.00
Cocrystal Pharma (COCP) United States $0.025B 0.00
Biora Therapeutics (BIOR) United States $0.025B 0.00
BRIACELL THERAP (BCTX) Canada $0.025B 0.00
Equillium (EQ) United States $0.024B 0.00
SAB Biotherapeutics (SABS) United States $0.024B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
BioAffinity Technologies (BIAF) United States $0.022B 0.00
Aprea Therapeutics (APRE) United States $0.022B 0.00
UNITY Biotechnology (UBX) United States $0.022B 0.00
Femasys (FEMY) United States $0.021B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.021B 0.00
Forte Biosciences (FBRX) United States $0.020B 0.00
Orgenesis (ORGS) United States $0.019B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.019B 0.00
Synlogic (SYBX) United States $0.019B 0.00
Apollomics (APLM) United States $0.018B 0.00
Lumos Pharma (LUMO) United States $0.018B 0.00
Vincerx Pharma (VINC) United States $0.018B 0.00
VBI Vaccines (VBIV) United States $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Aptose Biosciences (APTO) Canada $0.015B 0.00
Talis Biomedical (TLIS) United States $0.015B 0.00
Sensei Biotherapeutics (SNSE) United States $0.015B 0.00
KALA BIO (KALA) United States $0.015B 0.00
Monopar Therapeutics (MNPR) United States $0.014B 0.00
Evaxion Biotech (EVAX) Denmark $0.014B 0.00
Longeveron (LGVN) United States $0.014B 0.00
Biorestorative Therapies (BRTX) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Galecto (GLTO) Denmark $0.013B 0.00
Cara Therapeutics (CARA) United States $0.013B 0.00
Purple Biotech (PPBT) Israel $0.013B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.013B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.012B 0.00
Organovo Holdings (ONVO) United States $0.012B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.012B 0.00
Kintara Therapeutics (KTRA) United States $0.012B 0.00
Senti Biosciences (SNTI) United States $0.011B 0.00
Elevai Labs (ELAB) United States $0.011B 0.00
AEterna Zentaris (AEZS) Canada $0.011B 0.00
Mustang Bio (MBIO) United States $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.010B 0.00
Chemomab Therapeutics (CMMB) Israel $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
ABVC BioPharma (ABVC) United States $0.008B 0.00
NuCana (NCNA) United Kingdom $0.008B 0.00
Cadrenal Therapeutics (CVKD) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Bionomics (BNOX) Australia $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
BioCardia (BCDA) United States $0.006B 0.00
AquaBounty Technologies (AQB) United States $0.006B 0.00
Telesis Bio (TBIO) United States $0.006B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Kineta (KA) United States $0.006B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Psyence Biomedical (PBM) United States $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.005B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.005B 0.00
Entero Therapeutics (ENTO) United States $0.005B 0.00
Virios Therapeutics (VIRI) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Novogen (KZIA) Australia $0.004B 0.00
NexImmune (NEXI) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Invo BioScience (INVO) United States $0.004B 0.00
TRACON Pharmaceuticals (TCON) United States $0.003B 0.37
Cingulate (CING) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Exicure (XCUR) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Tharimmune (THAR) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Seelos Therapeutics (SEEL) United States $0.002B 0.00
Notable Labs (NTBL) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Dermata Therapeutics (DRMA) United States $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.001B 0.00
GRI Bio (GRI) United States $0.001B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.001B 0.00
CNS Pharmaceuticals (CNSP) United States $0.001B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00